Focus Surgery posts 1994 results
Focus Surgery's net loss widened last year as the company geared up its sales and marketing effortfor Sonablate 200, which uses high-intensity focused ultrasoundto treat benign prostatic hyperplasia (SCAN 9/28/94). The Fremont,CA, firm reported total
Focus Surgery's net loss widened last year as the company geared up its sales and marketing effortfor Sonablate 200, which uses high-intensity focused ultrasoundto treat benign prostatic hyperplasia (SCAN 9/28/94). The Fremont,CA, firm reported total revenues for 1994 (end-December) of $1.6million, compared to total revenues of $1.9 million the year before.Focus Surgery's net loss grew to $7.7 million, compared to $6.6million in 1993. Sonablate 200 was granted German regulatory approvallast year and Focus has made six commercial sales worldwide. Focusis working on a premarket approval (PMA) application to the Foodand Drug Administration to sell the system in the U.S.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
